您当前的位置：首页 > 文传商讯 > 正文

Angelini Pharma and Quiver Bioscience Announce Strategic Research Collaboration and Licensing Agreement to Discover and Advance Novel Therapeutics for Genetic Epilepsies

2026年02月26日 02:49:43来源：作者：

【摘要】 Angelini Pharma secures exclusive global license rights to future identified drug targetsQuiver receives undisclosed advance payment and is eligible for future milestone-dependent payments and royaltiesCollaboration further expands Angelini

Angelini Pharma secures exclusive global license rights to future identified drug targets
Quiver receives undisclosed advance payment and is eligible for future milestone-dependent payments and royalties
Collaboration further expands Angelini Pharma’s focus on brain health, building on its deep therapeutic expertise and drug development experience

责任编辑： admin

看新闻，关注新闻

相关阅读

分享到：

版权和免责申明

珠海都市网所有文字、图片、视频、音频等资料均来自互联网，不代表本站赞同其观点，本站亦不为其版权负责。相关作品的原创性、文中陈述文字以及内容数据庞杂本站无法一一核实，如果您发现本网站上有侵犯您的合法权益的内容，请联系我们，本网站将立即予以删除！

焦点新闻

热图要闻

热门排行